<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35552501</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study.</ArticleTitle><Pagination><StartPage>4604</StartPage><EndPage>4610</EndPage><MedlinePgn>4604-4610</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11154-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Long coronavirus disease (Long-COVID) syndrome is a hitherto poorly understood phenomenon with a broad spectrum of symptoms, including depression and anxiety. Depressive symptoms have been associated with brainstem raphe (BR) alterations in transcranial sonography (TCS) that might reflect dysfunction of the serotonergic system. The primary aim was to investigate the connection of BR alterations with depressive and anxiety symptoms in patients with Long-COVID syndrome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a cross-sectional study design, we included outpatients fulfilling the criteria of Long-COVID syndrome. All patients were examined by TCS in the axial plane with focus on BR signal alterations. The Hospital Anxiety and Depression Scale (HADS) was used to test for symptoms of anxiety and depression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included n&#x2009;=&#x2009;70 patients with Long-COVID syndrome, of which 28.6% (n&#x2009;=&#x2009;20) exhibited a reduced echogenicity of BR in the TCS examination. Patients with hypoechogenic BR had higher subscores for anxiety and depression compared to normoechogenic patients (HADS depression: median 8 versus 5.5, p&#x2009;=&#x2009;0.006; HADS anxiety: median 9 versus 6.5, p&#x2009;=&#x2009;0.006). After adjustment for reasonable confounders, only the odds ratio (OR) for relevant depressive symptoms was higher among Long-COVID patients with hypoechogenic raphe (adjusted OR 3.884, 95% CI 1.244-12.123).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Hypoechogenic BR alterations are independently associated with depressive symptoms in Long-COVID patients but are not highly frequent. Future studies should investigate whether the hypoechogenicity of the BR is a direct consequence or whether it reflects a priori a higher susceptibility to depressive symptoms after COVID-19, thus enabling to identify COVID-19 patients at higher risk of developing Long-COVID depressive symptoms.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulze</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Jeyanthan Charles</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siems</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trampe</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Ruhr-University, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Krogias</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Ruhr-University, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Faissner</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3412-762X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. simon.faissner@rub.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Ruhr-University, Bochum, Germany. simon.faissner@rub.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="Y">Depression</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="N">Ultrasonography, Doppler, Transcranial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>14</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35552501</ArticleId><ArticleId IdType="pmc">PMC9098142</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11154-3</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11154-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsivgoulis G, Palaiodimou L, Katsanos AH, et al. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord. 2020;13:1756286420932036. doi: 10.1177/1756286420932036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286420932036</ArticleId><ArticleId IdType="pmc">PMC7284455</ArticleId><ArticleId IdType="pubmed">32565914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladopoulos T, Zand R, Shahjouei S, et al. COVID-19: neuroimaging features of a pandemic. J Neuroimaging. 2021;31(2):228&#x2013;243. doi: 10.1111/jon.12819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12819</ArticleId><ArticleId IdType="pmc">PMC8014046</ArticleId><ArticleId IdType="pubmed">33421032</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogias C, Strassburger K, Eyding J, et al. Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography. J Psychiatry Neurosci. 2011;36(3):187&#x2013;194. doi: 10.1503/jpn.100067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/jpn.100067</ArticleId><ArticleId IdType="pmc">PMC3080514</ArticleId><ArticleId IdType="pubmed">21138658</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D, Woitalla D, Muhlack S, Gold R, T&#xf6;nges L, Krogias C. Brainstem raphe alterations in TCS: a biomarker for depression and apathy in Parkinson's disease patients. Front Neurol. 2018;9:645. doi: 10.3389/fneur.2018.00645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00645</ArticleId><ArticleId IdType="pmc">PMC6090021</ArticleId><ArticleId IdType="pubmed">30131761</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, Li DL, Tan XX, et al. A transcranial sonography study of brainstem and its association with depression in idiopathic generalized epilepsy with tonic-clonic seizures. Epilepsy Behav. 2020;102:106589. doi: 10.1016/j.yebeh.2019.106589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2019.106589</ArticleId><ArticleId IdType="pubmed">31726317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu Y, Han R, Liu K, Xing Y. Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients. Ther Adv Neurol Disord. 2021;14:17562864211007708. doi: 10.1177/17562864211007708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562864211007708</ArticleId><ArticleId IdType="pmc">PMC8047820</ArticleId><ArticleId IdType="pubmed">33912243</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogias C, Walter U. Transcranial sonography findings in depression in association with psychiatric and neurologic diseases: a review. J Neuroimaging. 2016;26(3):257&#x2013;263. doi: 10.1111/jon.12328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12328</ArticleId><ArticleId IdType="pubmed">27119431</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J Med Virol. 2020;92(10):1743&#x2013;1744. doi: 10.1002/jmv.25826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25826</ArticleId><ArticleId IdType="pmc">PMC7228370</ArticleId><ArticleId IdType="pubmed">32246784</ArticleId></ArticleIdList></Reference><Reference><Citation>Attademo L, Bernardini F. Are dopamine and serotonin involved in COVID-19 pathophysiology? Eur J Psychiatry. 2021;35(1):62&#x2013;63. doi: 10.1016/j.ejpsy.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpsy.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7598536</ArticleId><ArticleId IdType="pubmed">33162632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceravolo MG, Arienti C, de Sire A, et al. Rehabilitation and COVID-19: the cochrane rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med. 2020;56(5):642&#x2013;651. doi: 10.23736/S1973-9087.20.06501-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06501-6</ArticleId><ArticleId IdType="pubmed">32705860</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection A minimal common outcome measure set for COVID-19 clinical research. The Lancet Infect Dis. 2020;20(8):192&#x2013;7. doi: 10.1016/S1473-3099(20)30483-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter U, &#x160;koloud&#xed;k D. Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med. 2014;35(4):322&#x2013;331. doi: 10.1055/s-0033-1356415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1356415</ArticleId><ArticleId IdType="pubmed">24764215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratiuk AL, Pillay TD, Kon OM, Lalvani A. A conceptual framework to accelerate the clinical impact of evolving research into long COVID. Lancet Infect Dis. 2021;21(6):756&#x2013;757. doi: 10.1016/S1473-3099(21)00136-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00136-5</ArticleId><ArticleId IdType="pmc">PMC8062085</ArticleId><ArticleId IdType="pubmed">33894903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Mattar C, Zorumski CF, et al. Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA. 2020;324(22):2292&#x2013;2300. doi: 10.1001/jama.2020.22760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22760</ArticleId><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mpekoulis G, Frakolaki E, Taka S, et al. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform. PLoS One. 2021;16(6):0253458. doi: 10.1371/journal.pone.0253458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253458</ArticleId><ArticleId IdType="pmc">PMC8241096</ArticleId><ArticleId IdType="pubmed">34185793</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F, Palladini M, Paolini M, et al. Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study. Brain Behav Immun Health. 2021;18:100387. doi: 10.1016/j.bbih.2021.100387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8562046</ArticleId><ArticleId IdType="pubmed">34746876</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter U, Prudente-Morrissey L, Herpertz SC, Benecke R, Hoeppner J. Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res. 2007;155(1):67&#x2013;73. doi: 10.1016/j.pscychresns.2006.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pscychresns.2006.12.001</ArticleId><ArticleId IdType="pubmed">17391931</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker T, Becker G, Seufert J, et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry. 1997;63(5):590&#x2013;596. doi: 10.1136/jnnp.63.5.590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.63.5.590</ArticleId><ArticleId IdType="pmc">PMC2169833</ArticleId><ArticleId IdType="pubmed">9408098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>